<DOC>
	<DOC>NCT00332293</DOC>
	<brief_summary>The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.</brief_summary>
	<brief_title>AL-15469A for the Treatment of Bacterial Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Bacterial</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>signs and symptoms of bacterial conjunctivitis Other protocoldefined inclusion criteria may apply under 1 mo. age Other protocoldefined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>